News

Lamb Weston (LW) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended May 2025. This widely-known consensus outlook gives a

The market expects Helmerich & Payne (HP) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus

The market expects Reliance (RS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is

The market expects Globe Life (GL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook

Wall Street expects a year-over-year increase in earnings on higher revenues when Fiserv (FI) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important

General Dynamics (GD) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook

Wall Street expects a year-over-year decline in earnings on higher revenues when AT&T (T) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in

Inflation in the United States accelerated in June, indicating the early impact of new tariffs. The Consumer Price Index grew 2.7% year over year, up from the 2.4% increase in May and marking the

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 16th:

Fairfax Financial Holdings Limited FRFHF: This property and casualty insurance and

Gilat Satellite Networks (GILT) is a Zacks Rank #5 (Strong Sell) after the company recently posted a miss but the stock has soared since that earnings report.  This article will look at why this

Recursion Pharmaceuticals RXRX is strategically leveraging its AI-powered drug discovery platform through multiple high-value collaborations, positioning itself for long-term growth and

Morgan Stanley’s MS second-quarter 2025 earnings of $2.13 per share handily outpaced the Zacks Consensus Estimate of $1.93. Also, the bottom line rose 17% from the prior-year quarter.Unlike its Wall

IonQ. Inc. IONQ, a pioneer in quantum computing, is setting its sights far beyond Earth’s surface. With the recent acquisition of Capella Space, a satellite technology firm known for synthetic

Immunovant, Inc. (IMVT) closed the last trading session at $17.49, gaining 14.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Universal Health Services (UHS) closed the last trading session at $176.94, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

The price trend for The Japan Steel Works, Ltd. (JPSWY) has been bearish lately and the stock has lost 5.7% over the past two weeks. However, the formation of a hammer chart pattern in its last

Marex Group PLC (MRX) closed the last trading session at $39.49, gaining 0% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

GH Research PLC (GHRS) closed the last trading session at $15.99, gaining 33.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of VNET Group (VNET) have gained 62.9% over the past four weeks to close the last trading session at $9.04, but there could still be a solid upside left in the stock if short-term price

Shares of Ascendis Pharma A/S (ASND) have gained 1.1% over the past four weeks to close the last trading session at $174.75, but there could still be a solid upside left in the stock if short-term

Shares of Interpublic Group (IPG) have gained 5.1% over the past four weeks to close the last trading session at $24.19, but there could still be a solid upside left in the stock if short-term price

BioMarin Pharmaceutical (BMRN) closed the last trading session at $56.62, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

The price trend for TIM S.A. Sponsored ADR (TIMB) has been bearish lately and the stock has lost 6.4% over the past week. However, the formation of a hammer chart pattern in its last trading session

Comerica Incorporated CMA is scheduled to report second-quarter 2025 results on July 18, before the opening bell. The bank’s revenues are expected to increase while earnings are likely to decline

Verizon Communications Inc. VZ is scheduled to report second-quarter 2025 earnings on July 21. The Zacks Consensus Estimate for sales and earnings is pegged at $33.6 billion and $1.18 per share